Atlas Trials

3-AP Plus Cisplatin in Treating Patients With Recurrent or Metastatic Adenocarcinoma of the Esophagus or Gastroesophageal Junction

Clinical trial NCT00077545 · COMPLETED

Trial details

NCT number
NCT00077545
Sponsor
National Cancer Institute (NCI)
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Adenocarcinoma of the EsophagusRecurrent Esophageal CancerStage IV Esophageal Cancer
Start date
2004-01-01
Primary completion
2007-03-01
Enrollment
39

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.